Somatostatin receptors 3, 4 and 5 play important roles in gallbladder cancer

Run-Sheng Guo1, Pei-Dong Shi, Jie Zhou

  • 1Department of General Surgery, Jiading Central Hospital, Shanghai, China.

Insights

Somatostatin receptor subtypes (SSTRs) show altered expression in gallbladder cancer. SSTR5, SSTR3, and SSTR4 levels correlate with tumor differentiation and metastasis, suggesting their roles in gallbladder cancer development.

Area of Science:

  • Oncology
  • Molecular Biology
  • Gastroenterology

Background:

  • Gallbladder cancer (GBC) is a significant health concern with complex molecular underpinnings.
  • Somatostatin receptors (SSTRs) are implicated in various cancers, but their specific roles in GBC are not fully elucidated.

Purpose of the Study:

  • To investigate the expression patterns of five somatostatin receptor subtypes (SSTR1-5) in gallbladder cancer tissues.
  • To analyze the correlation between SSTR expression and key clinicopathological features of GBC.

Main Methods:

  • Immunohistochemical staining was employed to assess SSTR expression in 29 GBC and 25 normal gallbladder tissue specimens.
  • Statistical analysis, including chi-square tests, was used to determine relationships between SSTR expression and clinicopathological parameters.

Main Results:

  • All five SSTR subtypes were expressed in GBC tissues, with SSTR3 showing the highest expression.
  • SSTR5 expression was significantly elevated in GBC compared to normal tissues (P<0.05).
  • SSTR3 expression was higher in well/moderately differentiated GBC than poorly differentiated GBC (P<0.05), while SSTR4 was lower in tumors with lymph node metastasis (P<0.05).

Conclusions:

  • SSTR5, SSTR3, and SSTR4 expression levels are significantly associated with GBC development and progression.
  • These SSTR subtypes may serve as potential biomarkers or therapeutic targets for gallbladder cancer.